Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Human Genome Sciences, Inc.

http://www.hgsi.com

Latest From Human Genome Sciences, Inc.

The Greatest FDA Advisory Committees, Part III: The Power of The Patients

With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years.

Advisory Committees Drug Approval Standards

Deal Watch: Private Equity-Backed Covis Bids To Buy Troubled AMAG

Following a strategic review, AMAG goes to Covis. Vincera goes public in merger with blank check company, has pending cancer deal with Bayer.

Deals Business Strategies

Keeping Track: New Nucala Indication; BMS’ Ide-Cel Clears Filing Hurdle; First Applications From Telix And ADC Therapeutics

The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Approvals

How Cipla Is Aligning Manufacturing Amid The Pandemic

Cipla senior management executive tells Scrip how the company is calibrating manufacturing as part of a wider business “reimagination” and accelerated digital adoption across its operations.

Commercial Strategy
See All

Company Information

UsernamePublicRestriction

Register